Smith & Nephew
- Market cap
- 11.25B
- P/E (TTM)i
- 18.29
- P/Bi
- 2.17
- EPSi
- 1.43
- Div yieldi
- 2.91%
- 52W posi
- 8%
Anonymous reader poll. Unscientific, not investment advice.
About Smith & Nephew
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
- Founded
- 1856
- CEO
- Mr. Deepak S. Nath
- Employees
- 16,988
- Headquarters
- Watford, Herefordshire, United Kingdom of Great Britain and Northern Ireland (the)
- Fiscal year end
- 12-31
- Website
- smith-nephew.com
Company profile
- Exchange
- US
- Symbol
- SNN
- Market-cap rank
- #1382
- Listing date
- 1970-01-01
- Market cap
- 11.25B
- Float cap
- 11.14B
- Shares out
- 418.52M
- Float shares
- 414.10M
Sectors & themes
Quote time 2026-10-08 04:47:38 · For reference only, not investment advice and not tailored to your situation.